Jan Kajstura

Active 1994–2013

110
Papers
44,218
Citations
97
h-index
110
i10-index

Citations

Citations per year for Jan Kajstura1981: 2 citations1982: 2 citations1988: 1 citations1992: 2 citations1994: 2 citations1995: 7 citations1996: 32 citations1997: 114 citations1998: 207 citations1999: 265 citations2000: 307 citations2001: 288 citations2002: 505 citations2003: 617 citations2004: 668 citations2005: 640 citations2006: 731 citations2007: 648 citations2008: 628 citations2009: 484 citations2010: 600 citations2011: 590 citations2012: 578 citations2013: 464 citations2014: 447 citations2015: 344 citations2016: 290 citations2017: 236 citations2018: 255 citations2019: 459 citations2020: 421 citations2021: 362 citations2022: 204 citations2023: 144 citations2024: 191 citations2025: 83 citations2026: 3 citations1983–1987: no citations, so these years are not shown1989–1991: no citations, so these years are not shown1993: no citations, so this year is not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 3,222 citing papers, 36.3% of this breakdownChina: 682 citing papers, 7.7% of this breakdownGermany: 584 citing papers, 6.6% of this breakdownItaly: 573 citing papers, 6.5% of this breakdownUnited Kingdom: 516 citing papers, 5.8% of this breakdownJapan: 414 citing papers, 4.7% of this breakdownCanada: 300 citing papers, 3.4% of this breakdownNetherlands: 208 citing papers, 2.3% of this breakdownFrance: 197 citing papers, 2.2% of this breakdownAustralia: 181 citing papers, 2% of this breakdownSpain: 156 citing papers, 1.8% of this breakdownSouth Korea: 129 citing papers, 1.5% of this breakdown
0%36.3%Other 19.2%

Fields

  • Medicine62.2%
  • Biochemistry, Genetics and Molecular Biology31.5%
  • Neuroscience1.6%
  • Engineering1.4%
  • Materials Science1.1%
  • Immunology and Microbiology1%
  • Other1.2%

Topics

  • Tissue Engineering and Regenerative Medicine7.9%
  • Mesenchymal stem cell research7.5%
  • Cardiac Fibrosis and Remodeling4.3%
  • Congenital heart defects research4.3%
  • Electrospun Nanofibers in Biomedical Applications3.1%
  • Pluripotent Stem Cells Research3.1%
  • Other69.8%

Coauthors

All papers

Open in search
  1. Bone marrow cells regenerate infarcted myocardium

    Authors: , , , , , , , , , , , - Nature 2001 cited by 5,177

  2. Adult Cardiac Stem Cells Are Multipotent and Support Myocardial Regeneration

    Authors: , , , , , , , , , , , , , - Cell 2003 cited by 3,542

  3. Apoptosis in the Failing Human Heart

    Authors: , , , , , , , , , , , - New England Journal of Medicine 1997 cited by 1,683

  4. Oxidative Stress–Mediated Cardiac Cell Death Is a Major Determinant of Ventricular Dysfunction and Failure in Dog Dilated Cardiomyopathy

    Authors: , , , , , , , , - Circulation Research 2001 cited by 381

  5. Senescence and Death of Primitive Cells and Myocytes Lead to Premature Cardiac Aging and Heart Failure

    Authors: , , , , , , , , , , , - Circulation Research 2003 cited by 388

  6. Myocardial Cell Death in Human Diabetes

    Authors: , , , , , , , - Circulation Research 2000 cited by 798

  7. Stretch-induced programmed myocyte cell death.

    Authors: , , , , , , , , - Journal of Clinical Investigation 1995 cited by 650

  8. Apoptotic and necrotic myocyte cell deaths are independent contributing variables of infarct size in rats.

    Authors: , , , , , , , , - 1996 cited by 1,044

  9. Cardiac Stem Cell and Myocyte Aging, Heart Failure, and Insulin-Like Growth Factor-1 Overexpression

    Authors: , , , , , , , , , , , , , , - Circulation Research 2004 cited by 540

  10. Ablation of telomerase and telomere loss leads to cardiac dilatation and heart failure associated with p53 upregulation

    Authors: , , , , , , , , , - The EMBO Journal 2002 cited by 309

  11. Exogenous High-Mobility Group Box 1 Protein Induces Myocardial Regeneration After Infarction via Enhanced Cardiac C-Kit + Cell Proliferation and Differentiation

    Authors: , , , , , , , , , , , , , , - Circulation Research 2005 cited by 286

  12. Ventricular Myocytes Are Not Terminally Differentiated in the Adult Mammalian Heart

    Authors: , - Circulation Research 1998 cited by 388

  13. Intracoronary Delivery of Autologous Cardiac Stem Cells Improves Cardiac Function in a Porcine Model of Chronic Ischemic Cardiomyopathy

    Authors: , , , , , , , , , - Circulation 2013 cited by 235

  14. Evidence That Human Cardiac Myocytes Divide after Myocardial Infarction

    Authors: , , , , , , , , , , - New England Journal of Medicine 2001 cited by 1,421

  15. Myocyte Death, Growth, and Regeneration in Cardiac Hypertrophy and Failure

    Authors: , , , - Circulation Research 2003 cited by 501

  16. Anthracycline Cardiomyopathy Is Mediated by Depletion of the Cardiac Stem Cell Pool and Is Rescued by Restoration of Progenitor Cell Function

    Authors: , , , , , , , , , , , , , , - Circulation 2009 cited by 268

  17. Cardiac Progenitor Cells and Biotinylated Insulin-Like Growth Factor-1 Nanofibers Improve Endogenous and Exogenous Myocardial Regeneration After Infarction

    Authors: , , , , , , , , , , , , - Circulation 2009 cited by 218

  18. Cardiac-specific overexpression of insulin-like growth factor 1 attenuates aging-associated cardiac diastolic contractile dysfunction and protein damage

    Authors: , , , , , , , - American Journal of Physiology-Heart and Circulatory Physiology 2006 cited by 102

  19. RETRACTED: Cardiac stem cells in patients with ischaemic cardiomyopathy (SCIPIO): initial results of a randomised phase 1 trial

    Authors: , , , , , , , , , , , , , , , , , , , - The Lancet 2011 cited by 1,281

  20. Administration of Cardiac Stem Cells in Patients With Ischemic Cardiomyopathy: The SCIPIO Trial

    Authors: , , , , , , , , , , , , - Circulation 2012 cited by 432

  21. Myocyte Death in the Failing Human Heart Is Gender Dependent

    Authors: , , , , , , , - Circulation Research 1999 cited by 415

  22. Angiotensin II Induces Apoptosis of Adult Ventricular MyocytesIn Vitro

    Authors: , , , , , , - Journal of Molecular and Cellular Cardiology 1997 cited by 413

  23. IGF-1 Overexpression Inhibits the Development of Diabetic Cardiomyopathy and Angiotensin II–Mediated Oxidative Stress

    Authors: , , , , , , , , , - Diabetes 2001 cited by 394

  24. Diabetes Promotes Cardiac Stem Cell Aging and Heart Failure, Which Are Prevented by Deletion of the p66 shc Gene

    Authors: , , , , , , , , , , , , , , , - Circulation Research 2006 cited by 330